Chronic myeloid leukemia (CML) is a clonal disorder characterized by BCR/ABL, a constitutively activated tyrosine kinase generated from the reciprocal translocation between chromosomes 9 and 22 [1–5]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.